arrow
S

Sheroy Minocherhomji

Eli Lilly and Company
H指数:17
被引数:2,221

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Ames Concordance with the In Vivo Transgenic Rodent (TGR) Gene Mutation Assay for NDSRIs and Relative In Vivo TGR Potency with Nitrosamines with Robust Dose-Response Carcinogenicity Data
2026-01-300
PRE
APPLICATION OF ERROR-CORRECTED SEQUENCING TECHNOLOGIES FOR IN VIVO REGULATORY MUTAGENICITY ASSESSMENT

错误校正测序技术在体内调控诱变性评估中的应用

2025-11-080
PRE
Small-molecule inhibition of kinesin KIF18A reveals a mitotic vulnerability enriched in chromosomally unstable cancers
2023-12-2710
OAAI
Discovery and preclinical characterization of AMG 650, a first-in-class inhibitor of kinesin KIF18A motor protein with potent activity against chromosomally unstable cancers
2023-04-045
PRE
Error-corrected next-generation sequencing to advance nonclinical genotoxicity and carcinogenicity testing
2023-01-1619
PRE
The Key Characteristics of Carcinogens: Relationship to the Hallmarks of Cancer, Relevant Biomarkers, and Assays to Measure Them

致癌物的关键特征: 与癌症特征的关系,相关的生物标志物以及测量它们的方法

2020-10-0165
OAAI